Measurement of free polysaccharide in tetanus toxoid-conjugate vaccine using antibody/ammonium sulfate precipitation

Journal of Microbiology and Biotechnology

Volumn 13, Issue 3, 2003, Pages 469-472

  Yoo, Tae Hyeon ^a   Kim, Hyun Sung ^a,b   Park, Sung Sik ^a   Bang, Eun Young ^a   Oh, Yong K ^a   Kim, Li Seop ^a   Kim, Hun ^a,c   Hur, Byung Ki ^b   Ryu, Yeon Woo ^c   Kim, Jong Su ^a  

^a Green Cross Company   (South Korea)

^b Inha University   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Antibody ammonium sulfate precipitation; Haemophilus influenzae type b; Polyribosylribitol phosphate; Polysaccharide conjugate vaccine

Indexed keywords

AMMONIUM SULFATE; BACTERIAL POLYSACCHARIDE; BUFFER; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; SODIUM CHLORIDE; TETANUS ANTIBODY; TETANUS TOXOID;

ACID PRECIPITATION; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONJUGATE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG FORMULATION; REPRODUCIBILITY; SUPERNATANT;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE SEROTYPE B;

EID: 0037898445     PISSN: 10177825     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bae, C. S., K. N. Park, S. J. Ahn, S. J. Kim, and B. K. Hur. 2002. Development of a quardrivalent combined DTaP-HepB vaccine with a low toxicity and a stable HBsAg immunogenicity. J. Microbiol. Biotechnol. 12: 787-792.
2. Black, S. B., H. R. Shinefield, B. Fireman, R. Hiatt, M. Polen, and E. Vittinghoff. 1991. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatr Infect. Dis. J. 10: 97-104.
3. Black, S. B. and H. R. Shinefield. 1992. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: Extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatr Infect. Dis. J. 11: 610-613.
4. Chu, C., R. Scheerson, J. B. Robbins, and S. C. Rastogi. 1983. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates. Infect. Immun. 40: 245- 256.
5. England, S. and S. Seifter. 1990. In M. P. Deutscher (ed.). Guide to Protein Purification, pp. 285-306, Academic Press, Inc., U.S.A.
6. Eskola, J., H. Peltola, A. K. Takala, H. Kayhty, M. Hakulinen, V. Karanko, E. Kela, P. Rekola, P. R. Ronnberg, J. S. Samuelson, L. K. Gordon, and P. H. Makela. 1987. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N. Engl. J. Med. 317: 717-722.
7. The Directorate for the Quality of Medicines of Council of Europe. 2002. In: European Pharmacopoeia, 4th Edition, pp. 2182-2185.
8. Farr, R. S. 1958. A quantitative immunochemical measure of the primary interaction between I*BSA and antibody. J. Infect. Dis. 103: 239-262.
9. Guo, Y. Y., R. Anderson, J. McIver, R. K. Gupta, and G. R. Siber. 1998. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine. Biologicals 26: 33-38.
10. Kabat, E. A. and M. Mayer. 1961. Carbohydrates estimates. In: G. Thomas (ed.), Experimental Immunochemistry, pp. 531. Thomas Publishers, Springfield, U.S.A.
11. Kaythy, H., J. Eskola, H. Peltola, P. R. Ronnberg, E. Kela, V. Karanko, and L. Saarinen. 1991. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am. J. Dis. Child. 145: 223-227.
12. Klug, B. 1996. Stability testing in Haemophilus influenzae type b conjugate vaccines. Detv. Biol. Stand. 87: 263-267.
13. Lei, Q. P., D. H. Lamb, R. Heller, and P. Pietobon. 2000. Quantitation of low level unconjugated polysaccharide in tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid separation by deoxycholate/HC1. J. Pharmaceut. Biomed. 21: 1087-1091.
14. Lei, Q. P., A. G. Shannon, R. Heller, and D. H. Lamb. 2000. Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines. Dev. Biol. 103: 259-264.
15. Peltola, H., H. Kayhty, A. Sivenon, and H. Makela. 1977. Haemophilus influenzae type b capsular polysaccharide vaccine in children: A double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 60: 730-737.
16. Scheerson, R., O. Barrera, and A. Sutton. 1980. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J. Exp. Med. 152: 361-376.
17. Smith, D. H., G. Peter, D. L. Ingram, A. L. Harding, and P. Anderson. 1973. Responses of children immunized with the capsular polysaccharide of Haemophilus influenzae type b. Pediatrics 52: 637-644.
18. Weinberg, G. A. and D.M. Granoff. 1988. Polysaccharideprotein conjugate vaccines for the prevention of Haemophilus influenzae type b disease. J. Pediatr 113: 621-631.